Fact CheckerSign in

NCT05982561Recruiting

Clinical Evaluation of BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer

Source: ClinicalTrials.gov · Last updated 23 Apr 2026

Brief summary (registry, in English)

BCDx is a urine-based multi-omic assay for early cancer recurrence detection in patients with a history of bladder cancer. This prospective, blinded study evaluates its efficacy in detecting recurrent NMIBC, offering a noninvasive monitoring solution.

Status (registry)
Recruiting
Study type
Observational
Enrollment
500 (estimated)
First submitted
27 Jul 2023
Start date
26 Jul 2023
Primary completion date
31 Aug 2026
Lead sponsor
Early is Good Inc.
NCT number
NCT05982561

What you commit to

  • Study type: Observational
  • Planned participants: 500
  • From 26 Jul 2023 to the primary completion date, 31 Aug 2026
  • 3 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients planning to undergo radical cystectomy or chemotherapy-radiation for Urothelial Cell Carcinoma.

Who the study is looking for

  • Patients 18 Years and older
  • Patients who have been diagnosed with incident or recurrent NMIBC within the past 2 years and undergoing standard of care/routine monitoring cystoscopy.
  • Patients who are able to provide legally effective informed consent.
  • Patients who are able to provide minimum 30mL of voided urine.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (3)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Indiana University School of Medicine
Coordinator of this site? Confirm its status
IndianapolisUnited StatesRecruiting
Arkansas Urology Research Center
Coordinator of this site? Confirm its status
Little RockUnited StatesRecruiting
Washington University
Coordinator of this site? Confirm its status
St LouisUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.